PLPatty J. Lee

Patty J. Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Patty J. Lee has a total of 260 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cellular hallmarks and aging clock of the human lung parenchyma

    by Ke Xu, Grace S. Kim, Atharva Bhagwat, Sepideh E. Meimand, Vignesh V. Venkat, Giang Pham, Jing Zhang, Jamshid Abdul-Ghafar, Mohamad D. Bairakdar, Komal Dolasia, et al.

    Aging affects lung function, predisposing older adults to respiratory diseases; however, the cellular and molecular mechanisms of lung aging are not fully understood. Leveraging single-cell and spatial transcriptomics data from 184 and 70 lung parenchyma samples, respectively, we present an analytical platform to dissect the cell composition, gene expression modules, and regulatory changes linked to multiple hallmarks of lung aging. Our findings show cell type-specific age-association of senescence markers and a decline in alveolar cell proliferation, autocrine WNT signaling, and stemness indicators with advancing age. Analysis of myeloid cells reveals a global reduction in macrophage subsets and a surge in mitochondrial dysfunction and inflammatory signaling. In contrast, lung parenchyma T cells expand with age and exhibit heightened interferon gamma expression, cytotoxic activity, and exhaustion in older lung and blood samples, indicative of age-related immune dysfunction. Cell interaction and spatial analysis demonstrate aberrant myeloid-T cell cross-talk, leading to an increase in T cell chemotaxis and activation. Lastly, we use machine learning to predict lung biological age and identify putative biomarkers of lung aging and disease risk.

  • Open Access

    SenNet Portal: Build, Optimization and Usage

    by Katy Börner, Philip D Blood, Jonathan C Silverstein, Matthew Ruffalo, Rahul Satija, Nils Gehlenborg, Brendan Honick, Andreas Bueckle, Yashvardhan Jain, Danial Qaurooni, et al.

    Cellular senescence is a hallmark of aging and a driver of functional decline across tissues, yet its heterogeneity and context dependence have limited systematic study. The Common Fund’s Cellular Senescence Network (SenNet) Program addresses this challenge by generating multimodal, multi-tissue datasets that profile senescent cells across the human lifespan and complementary mouse models. The SenNet Data Portal ( https://data.sennetconsortium.org ) serves as the public gateway to these resources, providing open access to harmonized single-cell, spatial, imaging, transcriptomic, and proteomic data; senescence biomarker catalogs; and standardized protocols that can be used to comprehensively identify and characterize senescent cells in mouse and human tissue. As of April 2026, the portal hosts 2,041 publicly available human and mouse datasets across 15 organs using 6 general assay types. Experts from 13 Tissue Mapping Centers (TMCs) and 12 Technology Development and Application (TDAs) components contribute tissue data, analyze data, identify senescent biomarkers, and agree on panels for cross-tissue antibody harmonization. They also register human tissue data into the Human Reference Atlas (HRA) and develop user interfaces for the multiscale and multimodal exploration of this data. Built on a scalable hybrid cloud microservices architecture by the Consortium Organization and Data Coordinating Center (CODCC), the Portal enables data submission, management, integrated analysis, spatial context mapping, and harmonized access to cross-species data critical for aging research. This paper presents user needs, the Portal’s architecture, data processing workflows, and senescence-focused analytical tools; usage scenarios illustrating applications in biomarker discovery, quality benchmarking, hypothesis generation, spatial analysis, cost-efficient profiling, and cell distance distribution analysis; and utility and usage by the larger researcher community. Current limitations and planned extensions—including expanded spatial-omics releases and improved tools for senotype characterization—are discussed. SenNet protocols, code, and user interfaces are freely available on https://docs.sennetconsortium.org/apis .


  • Open Access

    Proximal Pulmonary Artery Stiffening as a Biomarker of Cardiopulmonary Aging

    by Ruben De Man, Zhongyu Cai, Pramath Doddaballapur, Nicole Guerrera, Alexandria Regan, Liqin Lin, Erica Schwarz, Aurelien Justet, Nebal S. Abu Hussein, Jack Di Palo, et al.

    The geroscience hypothesis suggests that understanding mechanisms underlying aging will enable us to delay and lessen age‐related disability and diseases. The role of mechanical factors has been increasingly appreciated in many aspects of the aging process. Here, we use mouse models to investigate changes in the biomechanics of the proximal pulmonary artery, lung function, and right ventricle function in aging. We found an age‐related decreased capacity to store energy and increased circumferential stiffness of the proximal pulmonary artery with age that is associated with a reorientation of collagen toward the circumferential direction, decreased exercise ability, and decreased function of the lung and right ventricle. The observed compromised mechanics in the proximal pulmonary artery are consistent across multiple mouse models of accelerated aging. Furthermore, transcriptional changes in the proximal pulmonary artery indicate that aging is associated with senescence of perivascular macrophages, adventitial fibroblasts, and medial smooth muscle cells. Older pulmonary arteries increase expression of genes associated with ECM turnover (including genes in the TGFβ pathway) and increased intercellular signaling amongst perivascular macrophages, fibroblasts, and smooth muscle cells. Our results provide promising biomarkers of aging for diagnosis and potential pathways and molecular targets for antiaging therapies.


  • Open Access

    Impact of different tissue dissociation protocols on endothelial cell recovery from developing mouse lungs

    by Francesco Palumbo, Miša Gunjak, Patty J. Lee, Stefan Günther, Anne Hilgendorff, István Vadász, Susanne Herold, Werner Seeger, Christian Mühlfeld, Rory E. Morty

    Flow cytometry and fluorescence-activated cell sorting are widely used to study endothelial cells, for which the generation of viable single-cell suspensions is an essential first step. Two enzymatic approaches, collagenase A and dispase, are widely employed for endothelial cell isolation. In this study, the utility of both enzymatic approaches, alone and in combination, for endothelial cell isolation from juvenile and adult mouse lungs was assessed, considering the number, viability, and subtype composition of recovered endothelial cell pools. Collagenase A yielded an 8-12-fold superior recovery of viable endothelial cells from lung tissue from developing mouse pups, compared to dispase, although dispase proved superior in efficiency for epithelial cell recovery. Single-cell RNA-Seq revealed that the collagenase A approach yielded a diverse endothelial cell subtype composition of recovered endothelial cell pools, with broad representation of arterial, capillary, venous, and lymphatic lung endothelial cells; while the dispase approach yielded a recovered endothelial cell pool highly enriched for one subset of general capillary endothelial cells, but poor representation of other endothelial cells subtypes. These data indicate that tissue dissociation markedly influences the recovery of endothelial cells, and the endothelial subtype composition of recovered endothelial cell pools, as assessed by single-cell RNA-Seq.


  • Reply to Suresh

    by Isabel S. Bazan, So-Jin Kim, Taylor A. Ardito, Yi Zhang, Peiying Shan, Maor Sauler, Patty J. Lee

  • Open Access

    Efficacy of Transcendental Meditation to Reduce Stress Among Health Care Workers

    by Sangeeta P. Joshi, An-Kwok Ian Wong, Amanda Brucker, Taylor A. Ardito, Shein-Chung Chow, Sandeep Vaishnavi, Patty J. Lee

    Health care workers (HCWs) are experiencing substantial stress and burnout, with recently reported burnout rates of 60% to 70%.1-4 The World Health Organization defines burnout as an occupational phenomenon resulting from chronic workplace stress that has not been successfully managed.5 Burnout is characterized by 3 dimensions: feelings of exhaustion, increased mental distance from the job or negativism, and reduced professional efficacy.6 The serious consequences of burnout, such as rapid turnover, limited patient access and care, and increased health expenditure, can adversely affect HCWs, health care organizations, and patients.3,6,7 As a result, the Joint Commission and the Department of Health and Human Services have called for prioritization of health care workforce resilience.8,9 However, organizational burnout mitigation strategies have a limited evidence base with regard to approaches and strategies.


  • Open Access

    Sex differences and altered mitophagy in experimental pulmonary hypertension

    by Isabel S. Bazan, So-Jin Kim, Taylor A. Ardito, Yi Zhang, Peiying Shan, Maor Sauler, Patty J. Lee

    Pulmonary hypertension (PH) is a debilitating condition characterized by increased pulmonary arterial pressures and remodeling of pulmonary arteries, leading to right heart failure. Women have a higher prevalence of PH, whereas men have more severe disease and poorer outcomes. Animal models also show female-predominant disease. Despite the known sex differences in PH, little is known about how pathogenesis differs between the sexes. There is growing evidence of mitochondrial dysfunction, as well as altered mitophagy in PH. We hypothesized that sexual dimorphism contributes to mitochondrial dysfunction and altered mitophagy in PH. Using mouse lung endothelial cells, we exposed both wild-type and Parkin−/− cells to hypoxia and measured the effects on mitochondrial function and mitophagy-associated proteins. Our results show that females have more Parkin expression at baseline as well as increased mitochondrial respiratory capacity when exposed to oxidative stress. Inhibition of Parkin increased metabolic activity but reduced cell proliferation but to different degrees depending on sex, with results differing by sex. Our findings demonstrate sexual dimorphism in mitophagy-associated proteins and in mitochondrial respiration, which may help shed light on how the pathogenesis of PH may differ between the sexes.


  • Open Access

    Immunofibrotic drivers of impaired lung function in postacute sequelae of SARS-CoV-2 infection

    by Hyung J. Chun, Elias Coutavas, Alexander B. Pine, Alfred I. Lee, Vanessa L. Yu, Marcus K. Shallow, Coral X. Giovacchini, Anne M. Mathews, Brian Stephenson, Loretta G. Que, et al.

    BACKGROUND: Individuals recovering from COVID-19 frequently experience persistent respiratory ailments, which are key elements of postacute sequelae of SARS-CoV-2 infection (PASC); however, little is known about the underlying biological factors that may direct lung recovery and the extent to which these are affected by COVID-19 severity. METHODS: We performed a prospective cohort study of individuals with persistent symptoms after acute COVID-19, collecting clinical data, pulmonary function tests, and plasma samples used for multiplex profiling of inflammatory, metabolic, angiogenic, and fibrotic factors. RESULTS: Sixty-one participants were enrolled across 2 academic medical centers at a median of 9 weeks (interquartile range, 6–10 weeks) after COVID-19 illness: n = 13 participants (21%) had mild COVID-19 and were not hospitalized, n = 30 participants (49%) were hospitalized but were considered noncritical, and n = 18 participants (30%) were hospitalized and in the intensive care unit (ICU). Fifty-three participants (85%) had lingering symptoms, most commonly dyspnea (69%) and cough (58%). Forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), and diffusing capacity for carbon monoxide (DLCO) declined as COVID-19 severity increased ( P < 0.05) but these values did not correlate with respiratory symptoms. Partial least-squares discriminant analysis of plasma biomarker profiles clustered participants by past COVID-19 severity. Lipocalin-2 (LCN2), MMP-7, and HGF identified by our analysis were significantly higher in the ICU group ( P < 0.05), inversely correlated with FVC and DLCO ( P < 0.05), and were confirmed in a separate validation cohort ( n = 53). CONCLUSION: Subjective respiratory symptoms are common after acute COVID-19 illness but do not correlate with COVID-19 severity or pulmonary function. Host response profiles reflecting neutrophil activation (LCN2), fibrosis signaling (MMP-7), and alveolar repair (HGF) track with lung impairment and may be novel therapeutic or prognostic targets. Funding: National Heart, Lung, and Blood Institute (K08HL130557 and R01HL142818), American Heart Association (Transformational Project Award), the DeLuca Foundation Award, a donation from Jack Levin to the Benign Hematology Program at Yale University, and Duke University.


  • PINK1 mediates the protective effects of thyroid hormone T3 in hyperoxia-induced lung injury

    by Yi Zhang, Guoying Yu, Naftali Kaminski, Patty J. Lee

    Hyperoxia can lead to respiratory failure and death. Our previous work demonstrates that oxidant and mitochondrial injury play a critical role in hyperoxia-induced acute lung injury (HALI). Recently, thyroid hormone has been demonstrated to promote mitochondrial survival in other models of lung injury, but its role in hyperoxia is unknown. Adult wild-type (WT) mice were pretreated with either nebulized triiodothyronine (T3, 40 μg/kg) for 1 or 3 days, or with propylthiouracil (PTU, 100 μg/kg), for 3 days. Following pretreatment, WT mice underwent 72 h of hyperoxia exposure. WT and PINK1−/− mice were pretreated with either nebulized T3 (40 μg/kg) for 3 days or no pretreatment before 72 h continuous hyperoxia exposure. Bronchoalveolar lavage (BAL), histological changes in cellular composition, and type I cytokine induction were assessed. Lung lysates for mitochondrial cellular bioenergetics markers were analyzed by Western blot. Hyperoxia caused a significant increase in BAL total cell counts and lung cellular infiltrates. Administration of PTU enhanced HALI, whereas T3 attenuated HALI, inflammation, and oxidants in WT mice. In addition, T3 pretreatment increased mitochondrial biogenesis/fusion/mitophagy and decreased ER stress and apoptosis. PINK1−/− mice were more susceptible to hyperoxia than WT mice. Notably, pretreatment with T3 did not attenuate HALI in PINK1−/− mice. In addition, T3 pretreatment increased mitochondrial anti-ROS potential, improved mitochondrial bioenergetics and mitophagy, and attenuated mitochondria-regulated apoptosis, all in a PINK1-dependent manner. Our results highlight a novel protective role for PINK1 in mediating the cytoprotective effects of thyroid hormone in HALI. Therefore, thyroid hormone may represent a potential therapy for ALI.


  • Pazopanib ameliorates acute lung injuries via inhibition of MAP3K2 and MAP3K3

    by Qianying Yuan, Abdul Basit, Wenhua Liang, Rihao Qu, Yi Luan, Chunguang Ren, Ao Li, Xin Xu, Xiaoqing Liu, Chun Yang, et al.

    MAP3K inhibition attenuates acute lung injuries in mice and reduced edema in lung transplantation recipients.